Cellular responses to ionising radiation of AT heterozygotes: differences between missense and truncating mutation carriers

Por Fernet, M, Moullan, N, Lauge, A, Stoppa-Lyonnet, D, Hall, J
Publicado em 2004

Increased risk of breast cancer among female relatives of patients with ataxia-telangiectasia: a causal relationship?

Por d'Almeida, A K, Cavaciuti, E, Dondon, M-G, Laugé, A, Janin, N, Stoppa-Lyonnet, D, Andrieu, N
Publicado em 2005

Multiplex PCR/liquid chromatography assay for detection of gene rearrangements: application to RB1 gene

Por Dehainault, C., Laugé, A., Caux-Moncoutier, V., Pagès-Berhouet, S., Doz, F., Desjardins, L., Couturier, J., Gauthier-Villars, M., Stoppa-Lyonnet, D., Houdayer, C.
Publicado em 2004

Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families

Por Janin, N, Andrieu, N, Ossian, K, Laugé, A, Croquette, M-F, Griscelli, C, Debré, M, Bressac-de-Paillerets, B, Aurias, A, Stoppa-Lyonnet, D
Publicado em 1999

Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation

Por de Plater, L, Laugé, A, Guyader, C, Poupon, M-F, Assayag, F, de Cremoux, P, Vincent-Salomon, A, Stoppa-Lyonnet, D, Sigal-Zafrani, B, Fontaine, J-J, Brough, R, Lord, C J, Ashworth, A, Cottu, P, Decaudin, D, Marangoni, E
Publicado em 2010